Decentralized Trials: Stakeholders Press FDA On Design Flexibility, Role Of HCPs, Harmonization

Clinical Trials word cloud
Stakeholders offer advice on how FDA can improve its draft guidance on decentralized clinical trials • Source: Pink Sheet/Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Clinical Trials

More from R&D